10-K.Info (Beta Test) Courtesy of Short Sands, LLC | ||||||||||||||
| ||||||||||||||
|
10-K.Info (Beta Test) Courtesy of Short Sands, LLC | |||
AMGEN INC | |||
Ticker: AMGN Fiscal Year: 2014 | |||
Consolidated Statements of Cash Flows | |||
Period Ending Dec 31, 2014 10-K (Filed: Feb 19, 2015) | |||
(In Millions, except shares in actual) | |||
12 Months Ended | 12 Months Ended | 12 Months Ended | |
Dec 31, 2014 | Dec 31, 2013 | Dec 31, 2012 | |
Cash flows from operating activities: | |||
Net income | $ 5,158 | 5,081 | 4,345 |
Depreciation and amortization | 2,092 | 1,286 | 1,088 |
Stock-based compensation expense | 408 | 403 | 362 |
Deferred income taxes | (108) | (189) | 28 |
Property, plant and equipment impairments | 97 | 19 | 178 |
Other items, net | (213) | 84 | (74) |
Changes in operating assets and liabilities, net of acquisitions: | |||
Trade receivables, net | 136 | (38) | 348 |
Inventories | 327 | (7) | (150) |
Other assets | (1) | (59) | 124 |
Accounts payable | 405 | (184) | 161 |
Accrued income taxes | (103) | (326) | 87 |
Legal reserve | 0 | 0 | (780) |
Other liabilities | 357 | 221 | 165 |
Net cash provided by operating activities | 8,555 | 6,291 | 5,882 |
Cash flows from investing activities: | |||
Purchases of property, plant and equipment | (718) | (693) | (689) |
Cash paid for acquisitions, net of cash acquired | (165) | (9,434) | (2,390) |
Purchases of intangible assets | (285) | 0 | (25) |
Purchases of marketable securities | (25,878) | (21,965) | (26,241) |
Proceeds from sales of marketable securities | 16,697 | 19,123 | 17,372 |
Proceeds from maturities of marketable securities | 4,199 | 5,090 | 1,994 |
Change in restricted investments, net | 533 | (520) | 0 |
Other | (135) | (70) | (11) |
Net cash used in investing activities | (5,752) | (8,469) | (9,990) |
Cash flows from financing activities: | |||
Net proceeds from issuance of debt | 4,476 | 8,054 | 4,933 |
Repayment of debt | (5,605) | (3,371) | (123) |
Repurchases of common stock | (138) | (832) | (4,607) |
Dividends paid | (1,851) | (1,415) | (1,118) |
Net proceeds from issuance of common stock in connection with the Company's equity award programs | 186 | 296 | 1,288 |
Other | 55 | (6) | 46 |
Net cash (used in) provided by financing activities | (2,877) | 2,726 | 419 |
(Decrease) increase in cash and cash equivalents | (74) | 548 | (3,689) |
Cash and cash equivalents at beginning of period | 3,805 | 3,257 | |
Cash and cash equivalents at end of period | 3,731 | 3,805 | 3,257 |
External Links | |
AMGEN INC (AMGN) Fiscal Year 2014 | |
Statements of 10-K in Excel | https://www.sec.gov/.../Financial.xlxs |
Complete 10-K in HTML | https://www.sec.gov/.../10-K.html |
Complete 10-K in XBRL | https://www.sec.gov/.../10-K-xbrl.zip |